Eribulin/Trastuzumab Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C156364
A chemotherapy regimen consisting of eribulin and trastuzumab that may be used in the treatment of recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive breast cancer. [ ]
Term info
Label
Eribulin/Trastuzumab Regimen
Synonyms
- Eribulin-Trastuzumab
- Eribulin/Trastuzumab
- Eribulin/Trastuzumab Regimen
- Halaven/Herceptin
- Trastuzumab-Eribulin
- Trastuzumab/Eribulin
- Trastuzumab/Eribulin Regimen
Subsets
NCIT_C160952, NCIT_C160950
NCI META CUI
CL563072
Preferred Name
Eribulin/Trastuzumab Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C156364